A Study of LY3471851 in Participants With Psoriasis

NCT04119557 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Placebo
DRUG: LY3471851

Sponsor

Nektar Therapeutics

Collaborators

[object Object]